A convenient synthesis of new NSAID esters containing amino acid, urea and amide moieties
By: Ivana Perković, Zrinka Rajić Džolić and Branka Zorc
Open Access
|Oct 2013References
- 1. D. Wang and R. N. DuBois, Eicosanoids and cancer,(2010) 181-193; DOI: 10.1038/nrc2809.
- 2. E. R. Rayburn, S. J. Ezell and R. Zhang, Anti-inflammatory agents for cancer therapy,(2009) 29-43.
- 3. B. Zawidlak-Wegrzynska, M. Kawalec, I. Bosek, M. Luczyk-Juzwa, G. Adamus, A. Rusin, P. Filipczak, M. Glowala-Kosinska, K. Wolanska, Z. Krawczyk and P. Kurcok, Synthesis and antiproliferative properties of ibuprofen-oligo(3-hydroxybutyrate) conjugates,2010) 1833-1842; DOI: 10.1016/j.ejmech.2010.01.020.
- 4. S. Fogli, I. Banti, F. Stefanelli, L. Picchianti, M. Digiacomo, M. Macchia, M. C. Breschi and A. Lapucci, Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells,(2010) 5100-5107; DOI: 10.1016/j.ejmech.2010.08.019.
- 5. W. Liu, J. Zhou, K. Bensdorf, H. Zhang, H. Liu, Y. Wang, H. Qian, Y. Zhang, A. Wellner, G. Rubner, W. Huang, C. Guo and R. Gust, Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives,(2011) 907-913; DOI:10.1016/j.ejmech.2011. 01.002.
- 6. Z. Rajić, D. Hadjipavlou-Litina, E. Pontiki, M. Kralj, L. Šuman and B. Zorc, The novel ketoprofen amides - Synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents,(2010) 641-652; DOI: 10.1111/j.1747-0285.2010.00963.x.
- 7. Z. Rajić, D. Hadjipavlou-Litina, E. Pontiki, J. Balzarini and B. Zorc, The novel amidocarbamate derivatives of ketoprofen: Synthesis and biological activity,(2010) 210-219; DOI: 10.1007/s00044-010-9309-2.
- 8. K. Wittine, K. Benci, Z. Rajić, B. Zorc, M. Kralj, M. Marjanović, K. Pavelić, E. De Clercq, G. Andrei, R. Snoeck, J. Balzarini and M. Mintas, The novel phosphoramidate prodrugs of NSAID 3-hydroxypropylamides: Synthesis, cytostatic and antiviral activity evaluations,(2009) 143-151; DOI: 10.1016/j.ejmech.2008.03.037.
- 9. I. Perković, I. Butula, M. Kralj, I. Martin-Kleiner, J. Balzarini, D. Hadjipavlou-Litina, A-M. Katsori and B. Zorc, Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy)carbamoylcarbazides as potential anticancer agents and antioxidants,(2012) 227-238; DOI: 10.1016/j.ejmch.2012.02.046.
- 10. Z. Rajić, I. Butula, B. Zorc, S. Kraljević Pavelić, K. Hock, K. Pavelić, L. Naesens, E. De Clercq, J. Balzarini, M. Przyborowska, T. Ossowski and M. Mintas, Cytostatic and antiviral evaluations of NSAID hydroxamic acids,(2009) 328-338; DOI: 10.1111/j.1747-0285. 2009.00774x.
- 11. Z. Rajić, I. Perković, I. Butula, B. Zorc, D. Hadjipavlou-Litina, E. Pontiki, S. Pepeljnjak and I. Kosalec, Synthesis and biological evaluation of-methyl and-ethyl NSAID hydroxamic acids,(2009) 1179-1187; DOI: 10.1080/14756360902779128.
- 12. B. Zorc, S. Antolić and I. Butula, Macromolecular prodrugs. I. Synthesis of some non-steroidal anti-inflammatory drug esters,(1993) 127-133.
- 13. M. Barbarić, M. Kralj, M. Marjanović, I. Husnjak, K. Pavelić, J. Filipović-Grčić, D. Zorc and B. Zorc, Synthesis and in vitro antitumor effect of diclofenac and fenoprofen thiolated and nonthiolated polyaspartamide-drug conjugates,(2007) 20-29; DOI: 10.1016/ j.ejmech.2006.08.009.
- 14. I. Kalčić, M. Zovko, M. Jadrijević-Mladar Takač, B. Zorc and I. Butula, Synthesis and reactions of some azolecarboxylic acid derivatives,(2003) 217-228.
- 15. I. Butula, B. Zorc and V. Vela, Reaktionen mit 1-Benzotriazol carbonsaurechlorid.VII. Die Umsetzung mit Aminosauren,(1981) 435-440. 418
Language: English
Page range: 409 - 418
Published on: Oct 22, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2013 Ivana Perković, Zrinka Rajić Džolić, Branka Zorc, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.